🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#CVCT2021 excellent summary by Dr Hahn (RTHahnMD ) on the issues/questions we need to consider in trials for treatment of tricuspid regurgitation Maurizio taramasso francesco maisano Faiez ZANNAD

Read the STS-ACC TVT Registry New Mitral Report: bit.ly/TMVRrSTS Mortality decreased for TEER at 30 days (5.6%-4.1%), 1 year (27.4%-22.0%). Mitral valve-in-valve 30-day mortality rate 3.9%.Michael Mack Vinod Thourani David J. Cohen, MD, MSc Nimesh Desai MD PhD JACC Journals SCAI American College of Cardiology

The nephrology fellowship interview

Join now for excellent teaching on TR #pcr #tricuspid

Right ventricular-pulmonary arterial coupling and afterload reserve in patients undergoing transcatheter tricuspid valve repair via PCRonline 🫀 pcronline.com/tiny/url/572084

#pcrtricuspid working group. Lots of ideas and lots of fun with colleagues

Great kick-off talk by ⁦Alison Duncan⁩ at the Berlin Edwards meeting.

Hear from Alison Duncan on aetiology of AR, Sanjeev Bhattacharyya on whether mild HVD matters, James Wilkinson 💙 discusses how to present information to patients, Richard Steeds & Margaret McCartney will debate screening for HVD, @RichardWhitloc2 discusses INR & mechanical valves...plus more!!

Congratulations to the track & programme directors #PCRLV Tiffany Patterson Nicole Karam, MD, PhD, FESC Gabor G Toth Alison Duncan Fabien Praz Univ.-Prof. Dr. Ralph Stephan von Bardeleben PCRonline 🫀 Davide Capodanno Victoria Delgado thomas modine Azeem Latib 🌟🌟🌟

#PCRLV very interesting case presented by Anna Sannino MD PhD FASE and discussions and presentations by Patricia Mahia Alison Duncan PaoloDenti @lenardconradi and excellent audience channeling questions through the app and managed by chat master @MadalinaGarbi

Wider clips preferred as first clip 84.3% subjects (XTW: 50.7%, NTW: 33.6%) • PMR: XTW > NT for MR reduction, w longer leaflets, large prolapse or wider jets, calcified leaflets or annulus and Barlow's or bileaflet prolapse. • SMR: NTW = XTW clips. From expand G4 #PCRLV

#PCRLV Tendyne Expanded Clinical 🎯 Low-rate of device-related adverse events 🎯 Reliable and sustainable MR elimination in >99% patients 🎯 All-cause 1 year mortality 30.8% 🎯 Procedure- or device-related 1-year mortality 15.7% 🎯 Risk factors mortality: PHT, age Small LV

#PCRLV Resolve Study: early experience, good safety profile and reliable MR elimination in real-world at 30D 🎯 improved Sp 🎯 Improved Quality of Life 🎯 Lower average mortality rate versus predicted surgical risk score 🎯 Reliable MR elimination 🎯 Reduced LVEDV and RVSP

#PCRLV Papillary muscle rupture often presents with pulmonary edema and cardiogenic shock. 🎯 TEER was safe and effective in reducing MR and improving hemodymanic parameters 🎯 TEER should be considered as an alternative or a bridge to emergent mitral valve surgery. By M. Shuvy.

On demand Imaging primary mitral regurgitation and selecting the most appropriate treatment for each patient #PCRLV marta sitges Patricia Mahia Alison Duncan You will learn more next March 2023 in Madrid PCR Imaging - stay tuned nicolas dumonteil Personal Court RPTR Nina Ajmone Marsan

#PCRimaging Excellent lecture on how to assess result of MV #TEER: 🫀 Multi-parametric approach for residual MR 🫀 MV gradient and area 🫀 PV flow pattern predicts prognosis 🫀 Priority to MR reduction than avoiding mild MS PCRonline 🫀 Alison Duncan #echofirst #CardioTwitter

After the #ACC23 presentation, do not miss this webinar👉The TRILUMINATE pivotal trial: impact on practice and perspectives via PCRonline 🫀 pcronline.com/tiny/url/651144 RTHahnMD francesco maisano Fabien Praz #PCRTV EAPCIPresident

After the Triluminate trial would you refer more 🧑‍🤝‍🧑🧑‍🤝‍🧑 with severe TR to TEER for tricuspid valve?PCRonline 🫀 Fabien Praz Anna Sannino MD PhD FASE francesco maisano Donal RTHahnMD Elena Romero #CardioTwitter Rodrigo Estévez Alison Duncan marta sitges Dabit Arzamendi pcronline.com/tiny/url/651144

What has been achieved is great. The goal is … “zero residual MR”!!! Appropriate selection of patients/MV anatomies for different centers with different levels of experience remains crucial to achieve such results. Fabien Praz francesco maisano Alison Duncan